Bevacizumab and central nervous system (CNS) hemorrhage

Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience

(2011) M. Khasraw et al.   ANNALS OF ONCOLOGY

Intracranial hemorrhage in patients treated with bevacizumab: Report of two cases

(2011) Takeshi Nishimura   WORLD JOURNAL OF GASTROENTEROLOGY

Bevacizumab and Paclitaxel for Breast Cancer Patients with Central Nervous System Metastases: A Case Series

(2009) Sana Intidhar Labidi et al.   Clinical Breast Cancer

Bevacizumab Safety in Patients with Central Nervous System Metastases

(2009) B. Besse et al.   CLINICAL CANCER RESEARCH

Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases

(2009) Mark A. Socinski et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Rupture of a Cerebral Arteriovenous Malformation in a Patient Treated with Bevacizumab

(2009) Tawee Tanvetyanon et al.   Journal of Thoracic Oncology

What is the risk of intracranial bleeding during anti-VEGF therapy?

(2008) Craig P. Carden et al.   NEURO-ONCOLOGY